Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Wolf

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
ACS Chemical Biology|December 22, 2017
Time-Resolved Tracking of Separately Internalized Neuropeptide Y<sub>2</sub> Receptors by Two-Color Pulse-ChaseJonathan Lotze, Philipp Wolf, Ulrike Reinhardt, et al.
The Prostate|August 9, 2006
A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancerUrsula Elsässer-Beile, Philipp Wolf, Dorothee Gierschner, et al.
The Prostate|November 30, 2007
Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID micePhilipp Wolf, Karen Alt, Patrick Bühler, et al.
Anticancer Research|December 13, 2005
Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancerUrsula Elsässer-Beile, Christian Leiber, Ulrich Wetterauer, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 20, 2021
[Management of COVID-19 mass casualty incidents in nursing and retirement homes]Wolfgang Schreiber, Philipp Wolf, Nicole Bigalke, et al.
Cells|September 13, 2025
Engineering of Humanized PSMA-Directed CAR T Cells for Potent and Specific Elimination of Prostate Cancer CellsTobias D Deller, Jamal Alzubi, Laura Mosti, et al.
Oncology Reports|January 1, 2010
Primary prostate cancer cultures are models for androgen-independent transit amplifying cellsPatrick Bühler, Philipp Wolf, Arndt Katzenwadel, et al.
Chembiochem : a European Journal of Chemical Biology|October 26, 2021
Orthogonal Peptide-Templated Labeling Elucidates Lateral ET<sub>A</sub> R/ET<sub>B</sub> R Proximity and Reveals Altered Downstream SignalingPhilipp Wolf, Alexander Mohr, Georgina Gavins, et al.
Urologia Internationalis|March 11, 2010
Comparison of gene expression in LNCaP prostate cancer cells after treatment with bicalutamide or 5-alpha-reductase inhibitorsPatrick Bühler, Thomas Fischer, Philipp Wolf, et al.
Biotechnology for Biofuels|January 12, 2018
Metabolic engineering of <i>Pichia pastoris</i> for production of isobutanol and isobutyl acetateWiparat Siripong, Philipp Wolf, Theodora Puspowangi Kusumoputri, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
ACS Chemical Biology|December 22, 2017
Time-Resolved Tracking of Separately Internalized Neuropeptide Y<sub>2</sub> Receptors by Two-Color Pulse-ChaseJonathan Lotze, Philipp Wolf, Ulrike Reinhardt, et al.
The Prostate|August 9, 2006
A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancerUrsula Elsässer-Beile, Philipp Wolf, Dorothee Gierschner, et al.
The Prostate|November 30, 2007
Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID micePhilipp Wolf, Karen Alt, Patrick Bühler, et al.
Anticancer Research|December 13, 2005
Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancerUrsula Elsässer-Beile, Christian Leiber, Ulrich Wetterauer, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 20, 2021
[Management of COVID-19 mass casualty incidents in nursing and retirement homes]Wolfgang Schreiber, Philipp Wolf, Nicole Bigalke, et al.
Cells|September 13, 2025
Engineering of Humanized PSMA-Directed CAR T Cells for Potent and Specific Elimination of Prostate Cancer CellsTobias D Deller, Jamal Alzubi, Laura Mosti, et al.
Oncology Reports|January 1, 2010
Primary prostate cancer cultures are models for androgen-independent transit amplifying cellsPatrick Bühler, Philipp Wolf, Arndt Katzenwadel, et al.
Chembiochem : a European Journal of Chemical Biology|October 26, 2021
Orthogonal Peptide-Templated Labeling Elucidates Lateral ET<sub>A</sub> R/ET<sub>B</sub> R Proximity and Reveals Altered Downstream SignalingPhilipp Wolf, Alexander Mohr, Georgina Gavins, et al.
Urologia Internationalis|March 11, 2010
Comparison of gene expression in LNCaP prostate cancer cells after treatment with bicalutamide or 5-alpha-reductase inhibitorsPatrick Bühler, Thomas Fischer, Philipp Wolf, et al.
Biotechnology for Biofuels|January 12, 2018
Metabolic engineering of <i>Pichia pastoris</i> for production of isobutanol and isobutyl acetateWiparat Siripong, Philipp Wolf, Theodora Puspowangi Kusumoputri, et al.
Pageof 8